Relay Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview

Relay Therapeutics

24/02/2025 22:00

* Relay Therapeutics Inc  RLAY.OQ   RLAY.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
26 for the period ending December 31 2024
    * The Cambridge Massachusetts-based  company is expected to
report
revenue of $6.08 million, according to the mean estimate from 10
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Relay Therapeutics Inc
is for
a loss of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is $20.00​, above​ its last closing price
of $3.92. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.76       -0.77      -0.63     Beat    17.9
 Jun. 30 2024  -0.73       -0.73      -0.69     Beat    5.8
 Mar. 31 2024  -0.69       -0.70      -0.62     Beat    12​
 Dec. 31 2023  -0.69       -0.73      -0.67     Beat    8
 ​​Sep.        -0.82       -0.83      -0.54     Beat    35
 30 2023                                                
 Jun. 30 2023  -0.84       -0.82      -0.81     Beat    0.7​
 Mar. 31 2023  -0.66       -0.69      -0.78     Missed  -12.8
 Dec. 31 2022  -0.71       -0.70      -0.56     Beat    20.3
 This summary was machine generated February 24 at 22:00 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)